MedMira is One of 25 Innovators From Around the World Recognized for
Applying Technology to Benefit Humanity
SAN JOSE, CA, and HALIFAX, NS, Sept. 10 /CNW/ - MedMira Inc., ("MedMira")
(TSX Venture: MIR, NASDAQ: MMIRF), a developer and marketer of rapid
diagnostics, announced today that it has been named a 2008 Tech Awards
Laureate, one of 25 global innovators recognized each year for applying
technology to benefit humanity and spark global change. The Tech Awards, a
signature program of The Tech Museum of Innovation, and presented by Applied
Materials, Inc., selected MedMira from among hundreds of nominations
representing 68 countries.
MedMira is being honoured as a Laureate in the health category for the
development of the Multiplo HBV/HIV/HCV rapid test, a three minute 3-in-1
rapid test built on the Company's patented flow-through technology platform.
This test is the only rapid test available with the ability to simultaneously
detect multiple diseases from a single specimen on a single cartridge. With a
focus on infectious diseases, MedMira is continually developing new rapid
tests on their patented technology platform and will soon launch a line of
rapid tests for the diagnosis of sexually transmitted diseases.
"We are incredibly honoured that MedMira is being recognized by The Tech
Awards as an organization whose ideas and execution of those ideas are making
a difference in the world," said Hermes Chan, president and CEO, MedMira Inc.
"We are very proud to be a Canadian and a Nova Scotia biotechnology company
being recognized on the world stage for our work. MedMira's key stakeholders,
including the provincial and federal governments, industry associations, and
investors are critical to our success. Their continued support will enable us
to bring new and advanced rapid diagnostics to people around the world."
The Tech Awards: Technology Benefiting Humanity is one of the premier
annual humanitarian awards programs in the world, recognizing technical
solutions that benefit humanity and address the most critical issues facing
our planet and its people. The awards program honors 25 scientists and
innovators annually alongside the recipient of the Global Humanitarian Award.
Laureates are selected by a prestigious panel of international judges
organized by the Center for Science, Technology, and Society at Santa Clara
University, and made up of Santa Clara University faculty as well as leaders
from educational and research institutions, industry and the public sector
around the world.
"This year's international roster of Laureates demonstrates the
exceptional and creative applications of both high and low-tech solutions to
change the world," said Peter Friess, president of The Tech. "By celebrating
the accomplishments of these 25 Laureates, we are encouraging future
innovators to harness the incredible power and promise of technology to solve
the challenges that confront us and make the world healthier, safer and more
Established in 2000, The Tech Awards recognize 25 Laureates in five
universal categories: education, equality, environment, economic development
and health. These Laureates have developed new technological solutions or
innovative ways to use existing technologies to significantly improve the
lives of people around the world. One Laureate in each category will receive a
$50,000 cash prize during the annual Awards Gala in San Jose, Calif. on
This year, the 2008 Laureates represent the truly global vision of the
program, spanning countries such as Senegal, Peru, Hungary, Canada, Namibia,
Germany, Egypt, India, United Kingdom, Laos and the United States. Their work
impacts people in many more countries worldwide.
Key sponsors supporting The Tech Awards include Applied Materials, Inc.,
Intel Corporation, Accenture, Microsoft, The Swanson Foundation, BD
Biosciences, Polycom, Genentech, Wells Fargo, SAP, eBay, KPMG, Cadence, The
Quattrone Foundation, Omidyar Network, NASDAQ OMX, HP, Google, Cisco, Scott
Cook and Signe Ostby, NBC11, Ogilvy Public Relations Worldwide, The Fairmont
San Jose, Montgomery Hotel, Marriott San Jose, American Airlines and
Siltronic. Key partners include Santa Clara University's Center for Science,
Technology, and Society, World Federation of United Nations Associations,
United Nations Development Programme, World Bank Institute, Catholic Relief
Services, The CORE Group, National Center for Technology Innovation and
For more information about The Tech Awards, visit www.techawards.org.
About The Tech Museum of Innovation
The Tech Museum of Innovation is a hands-on technology and science museum
for people of all ages and backgrounds. Located in San Jose, California - the
Capital of Silicon Valley - its mission, as a public-benefit corporation, is
to inspire the innovator in everyone. Through hands-on exhibits, educational
programs, the annual Tech Challenge team competition for youth, and the
internationally recognized Tech Awards, presented by Applied Materials, Inc.,
The Tech Museum of Innovation honors the past, celebrates the present, and
encourages the development of innovative ideas for a more promising future.
For more information about The Tech Museum of Innovation, visit
MedMira is a leading developer and manufacturer of flow-through rapid
diagnostics. The company's tests provide hospitals, labs, clinics and
individuals with reliable, rapid diagnosis for diseases such as HIV and
hepatitis C in just three minutes. The company's tests are sold under the
Reveal(R), MiraWell(R), MiraCare(TM) and Multiplo(TM) brands in global
markets. MedMira's rapid HIV test is the only one in the world to achieve
regulatory approvals in Canada, the United States, China and the European
Union. MedMira's corporate offices and manufacturing facilities are located in
Halifax, Nova Scotia, Canada. For more information visit MedMira's website at
This news release contains forward-looking statements, which involve risk
and uncertainties and reflect the company's current expectation regarding
future events. Actual events could materially differ from those projected
herein and depend on a number of factors including, but not limited to,
changing market conditions, successful and timely completion of clinical
studies, uncertainties related to the regulatory approval process,
establishment of corporate alliances and other risks detailed from time to
time in the company quarterly filings.
The TSX Venture Exchange has not reviewed and does not accept
responsibility for the adequacy or accuracy of this statement.
For further information:
For further information: Andrea Young, MedMira Inc., (902) 450-1588,
email@example.com; Dr. James Smith, MedMira Inc., (902) 450-1588,
firstname.lastname@example.org; Lisa Croel, The Tech Museum of Innovation, (408) 795-6219,
email@example.com; Analisa Schelle, Ogilvy PR, (415) 677-2721,